136 related articles for article (PubMed ID: 19787253)
1. Epigenetic regulation of the embryonic oncogene ERas in gastric cancer cells.
Yashiro M; Yasuda K; Nishii T; Kaizaki R; Sawada T; Ohira M; Hirakawa K
Int J Oncol; 2009 Nov; 35(5):997-1003. PubMed ID: 19787253
[TBL] [Abstract][Full Text] [Related]
2. ERas oncogene expression and epigenetic regulation by histone acetylation in human cancer cells.
Yasuda K; Yashiro M; Sawada T; Ohira M; Hirakawa K
Anticancer Res; 2007; 27(6B):4071-5. PubMed ID: 18225573
[TBL] [Abstract][Full Text] [Related]
3. Expression of ERas oncogene in gastric carcinoma.
Kaizaki R; Yashiro M; Shinto O; Yasuda K; Matsuzaki T; Sawada T; Hirakawa K
Anticancer Res; 2009 Jun; 29(6):2189-93. PubMed ID: 19528480
[TBL] [Abstract][Full Text] [Related]
4. Role of ES cell-expressed Ras (ERas) in tumorigenicity of gastric cancer.
Kubota E; Kataoka H; Aoyama M; Mizoshita T; Mori Y; Shimura T; Tanaka M; Sasaki M; Takahashi S; Asai K; Joh T
Am J Pathol; 2010 Aug; 177(2):955-63. PubMed ID: 20566745
[TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation and silencing of the BNIP3 gene in colorectal and gastric cancer.
Murai M; Toyota M; Suzuki H; Satoh A; Sasaki Y; Akino K; Ueno M; Takahashi F; Kusano M; Mita H; Yanagihara K; Endo T; Hinoda Y; Tokino T; Imai K
Clin Cancer Res; 2005 Feb; 11(3):1021-7. PubMed ID: 15709167
[TBL] [Abstract][Full Text] [Related]
6. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation and clinicopathological significance of RASAL1 gene in gastric cancer.
Chen H; Pan Y; Cheng ZY; Wang Z; Liu Y; Zhao ZJ; Fan H
Asian Pac J Cancer Prev; 2013; 14(11):6261-5. PubMed ID: 24377515
[TBL] [Abstract][Full Text] [Related]
8. Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis.
Hashimoto Y; Akiyama Y; Otsubo T; Shimada S; Yuasa Y
Carcinogenesis; 2010 May; 31(5):777-84. PubMed ID: 20080834
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancers.
Kaira K; Sunaga N; Tomizawa Y; Yanagitani N; Ishizuka T; Saito R; Nakajima T; Mori M
Int J Oncol; 2007 Jul; 31(1):169-73. PubMed ID: 17549418
[TBL] [Abstract][Full Text] [Related]
10. ERas is constitutively expressed in full term placenta of pregnant cows.
Roperto S; Russo V; Urraro C; Restucci B; Corrado F; De Falco F; Roperto F
Theriogenology; 2017 Nov; 103():162-168. PubMed ID: 28787666
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic modification of TLR4 promotes activation of NF-κB by regulating methyl-CpG-binding domain protein 2 and Sp1 in gastric cancer.
Kim TW; Lee SJ; Oh BM; Lee H; Uhm TG; Min JK; Park YJ; Yoon SR; Kim BY; Kim JW; Choe YK; Lee HG
Oncotarget; 2016 Jan; 7(4):4195-209. PubMed ID: 26675260
[TBL] [Abstract][Full Text] [Related]
12. The Role of Embryonic Stem Cell-expressed RAS (ERAS) in the Maintenance of Quiescent Hepatic Stellate Cells.
Nakhaei-Rad S; Nakhaeizadeh H; Götze S; Kordes C; Sawitza I; Hoffmann MJ; Franke M; Schulz WA; Scheller J; Piekorz RP; Häussinger D; Ahmadian MR
J Biol Chem; 2016 Apr; 291(16):8399-413. PubMed ID: 26884329
[TBL] [Abstract][Full Text] [Related]
13. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of RAS protein activator like-1 in gastric cancer.
Seto M; Ohta M; Ikenoue T; Sugimoto T; Asaoka Y; Tada M; Mohri D; Kudo Y; Ijichi H; Tateishi K; Otsuka M; Hirata Y; Maeda S; Koike K; Omata M
Int J Cancer; 2011 Mar; 128(6):1293-302. PubMed ID: 20473946
[TBL] [Abstract][Full Text] [Related]
15. Frequent epigenetic silencing of the folate-metabolising gene cystathionine-beta-synthase in gastrointestinal cancer.
Zhao H; Li Q; Wang J; Su X; Ng KM; Qiu T; Shan L; Ling Y; Wang L; Cai J; Ying J
PLoS One; 2012; 7(11):e49683. PubMed ID: 23152928
[TBL] [Abstract][Full Text] [Related]
16. Discovery of aberrant expression of R-RAS by cancer-linked DNA hypomethylation in gastric cancer using microarrays.
Nishigaki M; Aoyagi K; Danjoh I; Fukaya M; Yanagihara K; Sakamoto H; Yoshida T; Sasaki H
Cancer Res; 2005 Mar; 65(6):2115-24. PubMed ID: 15781621
[TBL] [Abstract][Full Text] [Related]
17. Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer.
Cheng YY; Yu J; Wong YP; Man EP; To KF; Jin VX; Li J; Tao Q; Sung JJ; Chan FK; Leung WK
Br J Cancer; 2007 Oct; 97(7):895-901. PubMed ID: 17848950
[TBL] [Abstract][Full Text] [Related]
18. Co-expression of laminin β3 and γ2 chains and epigenetic inactivation of laminin α3 chain in gastric cancer.
Ii M; Yamamoto H; Taniguchi H; Adachi Y; Nakazawa M; Ohashi H; Tanuma T; Sukawa Y; Suzuki H; Sasaki S; Imai K; Shinomura Y
Int J Oncol; 2011 Sep; 39(3):593-9. PubMed ID: 21617852
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of VEZT gene expression in human gastric cancer involves promoter methylation and miR-43c.
Guo X; Jing C; Li L; Zhang L; Shi Y; Wang J; Liu J; Li C
Biochem Biophys Res Commun; 2011 Jan; 404(2):622-7. PubMed ID: 21156161
[TBL] [Abstract][Full Text] [Related]
20. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
